J 2023

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

BEISHUIZEN, Auke; Karin MELLGREN; Mara ANDRES; Anne AUPERIN; Chris M BACON et al.

Základní údaje

Originální název

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

Autoři

BEISHUIZEN, Auke; Karin MELLGREN; Mara ANDRES; Anne AUPERIN; Chris M BACON; Simon BOMKEN; G A Amos BURKE; Birgit BURKHARDT; Laurence BRUGIERES; Alan K S CHIANG; Christine DAMM-WELK; Emanuele AMORE; Keizo HORIBE; Edita KABICKOVA; Tasneem KHANAM; Udo KONTNY; Wolfram KLAPPER; Laurence LAMANT; Le Deley MARIE-CECILE; Jan LOEFFEN; Elizabeth MACINTYRE; Georg MANN; Friederike MEYER-WENTRUP; Ulf MICHGEHL; Veronique MINARD-COLIN; Lara MUSSOLIN; Ilske OSCHLIES; Catherine PATTE; Marta PILLON; Alfred REITER; Charlotte RIGAUD; Leila RONCERY; Itziar SALAVERRIA; Ingrid SIMONITSCH-KLUPP; Anne UYTTEBROECK; Jaime VERDU-AMOROS; Denise WILLIAMS; Wilhelm WOESSMANN; Andrew WOTHERSPOON; Grazyna WROBEL; Martin ZIMMERMANN; Andishe ATTARBASCHI a Suzanne Dawn TURNER

Vydání

LANCET HAEMATOLOGY, Oxford, ELSEVIER SCI LTD, 2023, 2352-3026

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 15.400

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14740/23:00133642

Organizační jednotka

Středoevropský technologický institut

EID Scopus

Klíčová slova anglicky

LARGE-CELL; LYMPHOMA; MINIMAL RESIDUAL DISEASE; BURKITTS-LYMPHOMA; GENE-EXPRESSION

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 26. 2. 2024 00:17, Mgr. Eva Dubská

Anotace

V originále

The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.